Aspire Private Capital’s PetMed Express PETS Stock Holding History

Aspire Private Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-476	Closed	-$2.28K	–	735
2024 Q1	$2.28K	Hold	476	–	–	﹤0.01%	567
2023 Q4	$3.6K	Hold	476	–	–	﹤0.01%	510
2023 Q3	$4.88K	Hold	476	–	–	﹤0.01%	478
2023 Q2	$6.56K	Sell	476 -851	-64%	-$12.8K	﹤0.01%	422
2023 Q1	$21.6K	Buy	1,327 +4	+0.3%	+$75	0.01%	275
2022 Q4	$23.4K	Buy	1,323 +1,009	+321%	+$20K	0.01%	268
2022 Q3	$6K	Buy	314 +4	+1%	+$85	﹤0.01%	402
2022 Q2	$6K	Buy	310 +193	+165%	+$4.31K	﹤0.01%	385
2022 Q1	$3K	Buy	+117	New	+$3.03K	﹤0.01%	466

Other funds holding PETS

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspire Private Capital's PETS Position: Q2 2024 in Review

Aspire Private Capital sold out of PetMed Express (PETS) in Q2 2024, closing a stake of 476 shares — an estimated $2.28K sold.

Aspire Private Capital first reported a position in PETS in Q1 2022 and held it in 9 quarters. The position peaked at $23.4K in Q4 2022. 117 funds tracked by Wall St. Rank hold PETS as of Q2 2024.

Aspire Private Capital reported no remaining PetMed Express position as of Q2 2024 after selling out during the quarter.
Aspire Private Capital sold 476 PetMed Express shares in Q2 2024, an estimated $2.28K.
Aspire Private Capital first reported a position in PetMed Express in Q1 2022 and held it in 9 quarters.
Aspire Private Capital's PetMed Express position peaked at $23.4K in Q4 2022.
117 funds tracked by Wall St. Rank held PetMed Express as of Q2 2024.

Based on Aspire Private Capital's 13F filing for Q2 2024, filed 15 Jul 2024.